ArticleFrontiers in immunology2026
Commentary: Efficacy and safety of adding immune checkpoint inhibitors to standard chemotherapy or chemoradiotherapy for advanced or recurrent cervical cancer: a meta-analysis.
Hui Liu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.